Trial Outcomes & Findings for Veterans Service Organizations and My HealtheVet (MHV) (NCT NCT01597843)

NCT ID: NCT01597843

Last Updated: 2015-04-28

Results Overview

Measured by response to question: Have you ever used My HealtheVet online?

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

282 participants

Primary outcome timeframe

Baseline; After Group 1 Intervention; After Group 2 Intervention

Results posted on

2015-04-28

Participant Flow

We recruited 12 posts at the outset of the study, with the help of the Legion's state leadership. We invited all post members to complete surveys at times 0, 5 months and 10 months. The surveys were distributed by post leadership at a post meeting. We did not obtain informed consent; we obtained no personal identifiers but we obtained post.

Participant milestones

Participant milestones
Measure
Education in First Round
Four of twelve posts were in this group and were randomized to receive a series of training sessions. The training sessions were in person and on line, to educate post superusers who will in turn educate post members on the utility and mechanics of use of MHV. The participants at these 4 posts received the intervention in study months 1-5. They completed survey round 1 before receiving the intervention and survey rounds 2 and 3 after receiving the intervention. The number of participants at any post who showed up to respond to any of the three survey rounds varied.
Control First Round; Education in Second Round
Four of twelve posts were in this group and were randomized to receive a series of training sessions. The training sessions were in person and on line, to educate post superusers who will in turn educate post members on the utility and mechanics of use of MHV. The participants at these 4 posts received the intervention in study months 6-9. They completed survey rounds 1 and 2 before receiving the intervention and survey round 3 after they received the intervention. The number of participants at any post who showed up to respond to any of the three survey rounds varied.
Control First Round; Control Second Round; Intervention
Four of twelve posts were in this group and were randomized to receive a series of training sessions. The training sessions were in person and on line, to educate post superusers who will in turn educate post members on the utility and mechanics of use of MHV. The participants at these 4 posts received the intervention in study months 10 - 14. They completed all three survey rounds before receiving the intervention. The number of participants at any post who showed up to respond to any of the three survey rounds varied.
Overall Study
STARTED
79
122
81
Overall Study
Survey 1 Responses
45
71
59
Overall Study
Survey 2 Responses
52
42
58
Overall Study
Survey 3 Responses
65
56
76
Overall Study
COMPLETED
79
122
81
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Veterans Service Organizations and My HealtheVet (MHV)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Second Intervention Group
n=122 Participants
The group that receives the intervention second. The intervention is the same as for the first group. Education: Series of training sessions, in person and on line, to educate post superusers who will in turn educate post members on the utility and mechanics of use of MHV.
Education After Data Collection Complete
n=81 Participants
This group received a similar intervention, but after all quantitative data collection complete.
Total
n=282 Participants
Total of all reporting groups
First Educational Intervention Group
n=79 Participants
Group that receives intervention first. The intervention is a series of training sessions, in person and on line, to educate post superusers who will in turn educate post members on the utility and mechanics of use of MHV. Education: Series of training sessions, in person and on line, to educate post superusers who will in turn educate post members on the utility and mechanics of use of MHV.
Age, Continuous
65.0 Years
STANDARD_DEVIATION 10.7 • n=7 Participants
66.6 Years
STANDARD_DEVIATION 12.4 • n=5 Participants
67.1 Years
STANDARD_DEVIATION 11.4 • n=4 Participants
69.9 Years
STANDARD_DEVIATION 10.3 • n=5 Participants
Sex: Female, Male
Female
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Male
122 Participants
n=7 Participants
81 Participants
n=5 Participants
282 Participants
n=4 Participants
79 Participants
n=5 Participants
Proportion at Educational level
Less than high school
0.030 Proportion of participants
STANDARD_DEVIATION 0.17 • n=7 Participants
0.057 Proportion of participants
STANDARD_DEVIATION 0.23 • n=5 Participants
0.052 Proportion of participants
STANDARD_DEVIATION 0.22 • n=4 Participants
0.068 Proportion of participants
STANDARD_DEVIATION 0.25 • n=5 Participants
Proportion at Educational level
High school or GED
0.438 Proportion of participants
STANDARD_DEVIATION 0.50 • n=7 Participants
0.674 Proportion of participants
STANDARD_DEVIATION 0.469 • n=5 Participants
0.580 Proportion of participants
STANDARD_DEVIATION 0.494 • n=4 Participants
0.617 Proportion of participants
STANDARD_DEVIATION 0.48 • n=5 Participants
Proportion at Educational level
College or technical degree
0.479 Proportion of participants
STANDARD_DEVIATION 0.500 • n=7 Participants
0.233 Proportion of participants
STANDARD_DEVIATION 0.423 • n=5 Participants
0.315 Proportion of participants
STANDARD_DEVIATION 0.465 • n=4 Participants
0.241 Proportion of participants
STANDARD_DEVIATION 0.428 • n=5 Participants
Proportion at Educational level
Missing
0.053 Proportion of participants
STANDARD_DEVIATION 0.224 • n=7 Participants
0.036 Proportion of participants
STANDARD_DEVIATION 0.186 • n=5 Participants
0.053 Proportion of participants
STANDARD_DEVIATION 0.224 • n=4 Participants
0.074 Proportion of participants
STANDARD_DEVIATION 0.262 • n=5 Participants

PRIMARY outcome

Timeframe: Baseline; After Group 1 Intervention; After Group 2 Intervention

Population: Respondents to first round survey

Measured by response to question: Have you ever used My HealtheVet online?

Outcome measures

Outcome measures
Measure
Education in First Round
n=79 Participants
Series of training sessions, in person and on line, to educate post superusers who will in turn educate post members on the utility and mechanics of use of MHV. This group received the intervention during study months 1-5, following survey 1, prior to survey rounds 2 and 3.
Control First Round; Education in Second Round
n=122 Participants
The intervention was delivered to 3 groups of 4 posts in sequence. The posts in this second round received the intervention over the second study period, from month 6 through month 9. they completed survey rounds 1 and 2 before receiving the intervention, survey round 3 after.
Control First Round; Control Second Round; Intervention
n=81 Participants
This group received the intervention in study months 10 - 14. They completed all three survey rounds before receiving the intervention.
Registration for MHV
Baseline survey
6.7 Percentage of respondents who use MHV
12.7 Percentage of respondents who use MHV
11.9 Percentage of respondents who use MHV
Registration for MHV
Post first round survey
25.0 Percentage of respondents who use MHV
7.1 Percentage of respondents who use MHV
12.1 Percentage of respondents who use MHV
Registration for MHV
Post second round survey
33.9 Percentage of respondents who use MHV
25.0 Percentage of respondents who use MHV
13.2 Percentage of respondents who use MHV

Adverse Events

Education in First Round

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control First Round; Education in Second Round

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control First Round; Control Second Round; Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jeff Whittle, MD, MPH

Clement J Zablocki VA Medical Center

Phone: 414-384-2000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place